Back to Agenda
TOPIC 2 SESSION 6: Reporting Requirements in Special Situations in the Post-authorisation Phase and Case Studies
Session Chair(s)
Gaby L. Danan, MD, PHD
Pharmacovigilance Expert, GLD, France
Phil Tregunno
Deputy Director - Patient Safety Monitoring, Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom
Speaker(s)
Sarah Vaughan
Head of Vigilance Operations, Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom
Reporting Requirements in Special Situations in the Post-authorisation Phase and Case Studies
Have an account?